RenovoRx RNXT
NASDAQ RNXT
$1.25 +0.04 (+3.75%)
As of: Oct 21, 2026 · 3:43 PM EDT

RenovoRx (RNXT) Convertible Debt (2021)

Updated

RenovoRx's Convertible Debt came in at $5.3 million for Q4 2021, unchanged from the prior quarter.

Analysis

RenovoRx (RNXT) Convertible Debt (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 258.31 Bn 237.34 Bn 4.88 Bn
2 Abbott Laboratories 173.24 Bn 143.67 Bn 7.27 Bn
3 Danaher 163.70 Bn 147.51 Bn 3.61 Bn
4 Intuitive Surgical 152.89 Bn 132.31 Bn 1.96 Bn
5 Medtronic 118.89 Bn 84.14 Bn 6.34 Bn
6 Stryker 113.70 Bn 99.82 Bn 4.50 Bn
7 Boston Scientific 65.15 Bn 59.92 Bn 3.85 Bn
8 Becton Dickinson 53.35 Bn 50.50 Bn 2.32 Bn
9 Edwards Lifesciences 50.80 Bn 34.81 Bn 1.35 Bn
10 RenovoRx 58.41 Mn 19.45 Mn 766,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 5.30 Mn
Sep 30, 2021 5.30 Mn
API Access

RenovoRx Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=RNXT&period=max&api_key=YOUR_API_KEY